Results 251 to 260 of about 273,677 (294)
Some of the next articles are maybe not open access.

Medullary Thyroid Carcinoma

Endocrine Practice, 2013
This review outlines advances in the diagnosis, genetic testing, and progress in medullary thyroid cancer (MTC) treatment in light of the most recent evidence.English-language articles pertaining to MTC published up to 2012 were reviewed. The pertinent articles and their references were obtained and those considered relevant were reviewed for inclusion.
Marcio L, Griebeler   +2 more
openaire   +2 more sources

Histiocytic medullary reticulosis

The American Journal of Medicine, 1965
Abstract A patient is described with clinical and morphologic features seen in previously reported cases of histiocytic medullary reticulosis and with the unusual antemortem findings of bizarre histiocytes in the blood and bone marrow, as well as skin involvement.
R M, FRIEDMAN, N H, STEIGBIGEL
openaire   +2 more sources

Medullary thyroid carcinoma

Current Treatment Options in Oncology, 2003
Medullary thyroid carcinoma (MTC) is a neuroendocrine malignancy that occurs in hereditary (25%) and sporadic (75%) clinical settings. MTC is present in all patients with the multiple endocrine neoplasia type 2 syndromes. MTCs produce calcitonin, the measurement of which can indicate the presence of tumors in people who are at risk and the ...
openaire   +2 more sources

Medullary thyroid carcinoma

American Journal of Otolaryngology, 1993
Medullary thyroid carcinoma (MTC) comprises approximately 1–2% of thyroid malignancies and occurs in sporadic and heritable forms. Hereditary forms include multiple endocrine neoplasia (MEN) type 2A, familial medullary thyroid carcinoma (FMTC), and MEN type 2B.
Y L, Colson, S E, Carty
openaire   +2 more sources

Histiocytic Medullary Reticulosis

Australian and New Zealand Journal of Medicine, 1975
Summary: The clinical and pathological features of histiocytic medullary reticulosis (HMR) are described in five patients. Treatment by splenectomy and the MOPP routine resulted in a transient improvement in platelet and neutrophil counts and resolution of anaemia and apparent prolongation of survival in two of the five patients.The relationship of ...
J R, Sullivan   +3 more
openaire   +2 more sources

Primary medullary hemorrhage

Computerized Medical Imaging and Graphics, 1989
Two patients developed primary medullary hemorrhages. Both patients were normotensive. They were both receiving oral anticoagulation but the coagulation studies were not excessively prolonged at the time that the hemorrhage occurred. The diagnosis of primary medullary hemorrhage was established by CT findings.
L A, Weisberg   +3 more
openaire   +2 more sources

Medullary sponge kidney

The American Journal of Medicine, 1965
Abstract Twenty cases of medullary sponge kidney (MSK), diagnosed on the basis of urographic findings, are reported in tabular form, the pertinent literature is considered and the generally held concept of MSK as a distinct clinical and pathologic entity is critically examined. The available evidence does not support the distinctiveness of MSK. Rather,
R C, MORRIS   +3 more
openaire   +2 more sources

Medullary Sponge Kidney

The British Journal of Radiology, 1962
A case of medullary sponge kidney is presented, as little has been published in the British literature on this subject, apart from a paper by Rubin, Cosbie Ross and Turner (1959), and a case described by Pyrah and Hodgkinson (1960) in a discussion of nephrocalcinosis; the condition is also known as cystic disease of the renal pyramids.
openaire   +2 more sources

Medullary thyroid carcinoma

2011
Abstract Medullary thyroid carcinoma (MTC) is a rare calcitonin-secreting tumour of the parafollicular or C cells of the thyroid. As the C cells originate from the embryonic neural crest, MTC often have the clinical and histological features of neuroendocrine tumours.
Friedhelm Raue, Karin Frank-Raue
openaire   +1 more source

Medullary Thyroid Cancer

Surgical Oncology Clinics of North America, 2006
The goal in managing patients who have MTC is to detect and surgically remove disease at an early stage. Tumor marker-based biochemical screening and DNA-based genetic screening have created the opportunity for effective prophylactic surgery in patients at risk for hereditary MTC.
Y Nancy, You   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy